Influence of hemodialysis on circulating CD4 low CD25 high regulatory T cells in end-stage renal disease patients

Inflammation Research

Volumn 63, Issue 2, 2014, Pages 99-103

  Lisowska, Katarzyna A ^a   Dębska Ślizień, Alicja ^a   Jasiulewicz, Aleksandra ^a   Bryl, Ewa ^a   Witkowski, Jacek M ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

End stage renal disease; Hemodialysis; Inflammation; T regulatory cells

Indexed keywords

CD4 ANTIGEN; CREATININE; HEMOGLOBIN; INTERLEUKIN 2 RECEPTOR ALPHA;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; END STAGE RENAL DISEASE; ERYTHROCYTE COUNT; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84895076976     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-013-0679-z     Document Type: Article

References (15)

1. Amore A, Coppo R. Immunological basis of inflammation in dialysis. Nephrol Dial Transpl. 2002;17:16-24. (Pubitemid 34918874)
2. Dalrymple LS, Go AS. Epidemiology of acute infections among patients with chronic kidney disease. Clin J Am Soc Nephrol. 2008;3:1487-93.
3. Allegra V, Vasile A, Maschio M, Mengozzi G. Immune response after vaccination with recombinant hepatitis surface antigen in maintenance hemodialysis patients and healthy control. Nephron. 1992;61:339-40.
4. Lisowska KA, Dȩbska-Ślizień A, Jasiulewicz A, Heleniak Z, Bryl E, Witkowski JM. Hemodialysis affects phenotype and proliferation of CD4-positive T lymphocytes. J Clin Immunol. 2012;32:189-200.
5. Kurz P, Kohler H, Meuer S, Hutteroth T, Meyer zum Buschenfelde KH. Impaired cellular responses in chronic renal failure: evidence for a T cell defect. Kidney Int. 1986;29:1209-14. (Pubitemid 16094235)
6. Gerez L, Madar L, Shkolnik T, Kristal B, Arad G, Reshef A, Steinberger A, Ketzinel M, Sayar D, Shasha S, Kaempfer R. Regulation of interleukin-2 and interferon-gamma gene expression in renal failure. Kidney Int. 1991;40:266-72.
7. + T regulatory cells for immunosuppressive therapy. Cytometry. 2009;75:175-88.
8. Hendrikx TK, van Gurp EA, Mol WM, Schoordijk W, Sewgobind VD, Ijzermans JN, Weimar W, Baan CC. End-stage renal failure and regulatory activities of CD4+ CD25bright+ FoxP3+ T-cells. Nephrol Dial Transpl. 2009;24:1969-78.
9. Libetta C, Esposito P, Sepe V, Portalupi V, Margiotta E, Canevari M, Dal Canton A. Dialysis treatment and regulatory T cells. Nephrol Dial Transpl. 2010;25:1723-7.
10. Meier P, Golshayan D, Blanc E, Pascual M, Burnier M. Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD. J Am Soc Nephrol. 2009;20:1368-84.
11. Wang J, Ioan-Facsinay A, van der Voort EI, Huizinga TW, Toes RE. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol. 2007;37:129-38. (Pubitemid 46128793)
12. high regulatory T cells indiscriminately kill autologous activated T cells. Immunology. 2009;128:e287-95.
13. Afzali B, Edozie FC, Fazekasova H, Scottà C, Mitchell PJ, Canavan JB, Kordasti SY, Chana PS, Ellis R, Lord GM, John S, Hilton R, Lechler RI, Lombardi G. Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation. Clin J Am Soc Nephrol. 2013;8(8):1396-405.
14. Lisowska KA, Debska-Slizien A, Radzka M, Witkowski JM, Rutkowski B, Bryl E. Recombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes. Artif Organs. 2010;34:e77-84.
15. Bocian K, Borysowski J, Wierzbicki P, Wyzgal J, Klosowska D, Bialoszewska A, Paczek L, Górski A, Korczak-Kowalska G. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+ CD25+ Tregs. Nephrol Dial Transpl. 2010;25:710-7.